These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7871584)

  • 1. Role of graft in transplantation tolerance.
    Auchincloss H
    Transplantation; 1995 Feb; 59(3):450. PubMed ID: 7871584
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble CTLA4Ig modifies acute rejection of rat lung allografts without blocking accumulation of key cytokine transcripts.
    Matsumura Y; Zuo XJ; Prehn J; Linsley P; Marchevsky A; Kass R; Matloff J; Jordan SC
    Transplant Proc; 1995 Feb; 27(1):406-8. PubMed ID: 7879040
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of CTLA4Ig use for allograft immunosuppression.
    Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
    Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of combined costimulatory blockade in animal transplant model.
    Dharnidharka VR; Schowengerdt K; Skoda-Smith S
    Nat Med; 2000 Feb; 6(2):115. PubMed ID: 10655074
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
    Fu F; Li W; Lu L; Fung JJ; Thomson AW; Qian S
    Transplant Proc; 1999; 31(1-2):453. PubMed ID: 10083185
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF; Lin H; Wei RQ; Turka LA
    J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy of heart transplantation].
    Vassalli G
    Rev Med Suisse Romande; 2002 Mar; 122(3):145-8. PubMed ID: 12014252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation.
    Yanagida N; Nomura M; Yamashita K; Takehara M; Murakami M; Echizenya H; Konishi K; Kitagawa N; Furukawa H; Uede T; Todo S
    Transplant Proc; 2001; 33(1-2):573-4. PubMed ID: 11266963
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitogen hypotheses revisited: enhancement of allograft tolerance and replacement of transplantation procedures in treating cancer.
    Wimer BM
    Cancer Biother Radiopharm; 2000 Apr; 15(2):207-9. PubMed ID: 10803327
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction by soluble CTLA4 in a mouse skin transplant model.
    Tepper MA; Linsley PS; Tritschler D; Esselstyn JM
    Transplant Proc; 1994 Dec; 26(6):3151-4. PubMed ID: 7998099
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of tolerance to heart allografts in high responder rats by combining anti-CD4 with CTLA4Ig.
    Yin D; Fathman CG
    J Immunol; 1995 Aug; 155(4):1655-9. PubMed ID: 7636225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K; Chandraker A; Schaub M; Stadlbauer TH; Korom S; Peach R; Linsley PS; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1997 Aug; 159(4):1711-7. PubMed ID: 9257832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract]   [Full Text] [Related]  

  • 16. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
    Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
    J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
    Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
    Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28-pathway blockade with CTLA4Ig leads to prolongation of small bowel transplant survival in rats.
    Pescovitz MD; Yang R; Liu Q; Collins MH; Grosfeld JL
    Transplant Proc; 1994 Jun; 26(3):1618-9. PubMed ID: 8030059
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment.
    Li Y; Zheng XX; Li XC; Zand MS; Strom TB
    Transplantation; 1998 Nov; 66(10):1387-8. PubMed ID: 9846527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.